ADMA Logo

ADMA Biologics, Inc. (ADMA) 

NASDAQ
Market Cap
$3.79B
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
514 of 950
Rank in Industry
279 of 543

Largest Insider Buys in Sector

ADMA Stock Price History Chart

ADMA Stock Performance

About ADMA Biologics, Inc.

ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

Insider Activity of ADMA Biologics, Inc.

Over the last 12 months, insiders at ADMA Biologics, Inc. have bought $0 and sold $26.52M worth of ADMA Biologics, Inc. stock.

On average, over the past 5 years, insiders at ADMA Biologics, Inc. have bought $4.75M and sold $13.81M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 130,000 shares for transaction amount of $482,144 was made by Grossman Jerrold B (director) on 2023‑08‑30.

List of Insider Buy and Sell Transactions, ADMA Biologics, Inc.

2024-11-22SalePresident and CEO
48,967
0.0205%
$21.10$1.03M-12.04%
2024-11-22SaleCFO and Treasurer
15,000
0.0063%
$21.15$317,250-12.04%
2024-09-09Saledirector
9,000
0.0039%
$18.47$166,189+3.78%
2024-08-30SaleCOO and SVP, Compliance
24,150
0.0101%
$16.90$408,050+9.65%
2024-08-29Saledirector
136,861
0.0589%
$17.27$2.36M+9.44%
2024-08-27SalePresident and CEO
389,356
0.1665%
$17.29$6.73M+7.72%
2024-08-26SalePresident and CEO
236,889
0.103%
$17.69$4.19M+6.93%
2024-08-23Saledirector
60,000
0.0255%
$18.26$1.1M+1.36%
2024-06-14SalePresident,CEO, and Interim CFO
100,000
0.044%
$10.72$1.07M+66.37%
2024-03-19Saledirector
411,829
0.1772%
$6.08$2.5M+158.80%
2024-03-18Saledirector
49,887
0.0221%
$6.01$299,821+169.19%
2024-03-15Saledirector
183,008
0.0805%
$6.01$1.1M+166.44%
2024-03-14Saledirector
448,276
0.1906%
$6.05$2.71M+163.62%
2024-03-13Saledirector
407,000
0.1776%
$6.21$2.53M+152.08%
2023-08-30Purchasedirector
130,000
0.0588%
$3.71$482,144+44.74%
2023-08-24Purchasedirector
25,000
0.0108%
$3.90$97,500+36.05%
2023-08-22Saledirector
1.43M
0.637%
$3.87$5.54M+35.92%
2023-08-18SalePresident and CEO
250,000
0.1139%
$4.15$1.04M+27.07%
2023-08-16SalePresident and CEO
3
<0.0001%
$4.38$13+16.78%
2023-08-16SaleEVP, CFO
178,184
0.0804%
$4.45$793,400+16.78%

Insider Historical Profitability

<0.0001%
ELMS STEVEdirector
2115671
0.895%
$16.0205
Grossman Adam SPresident and CEO
1989007
0.8414%
$16.02377<0.0001%
Grossman Jerrold Bdirector
467305
0.1977%
$16.02171<0.0001%
Kestenberg-Messina Kaitlin M.COO and SVP, Compliance
449088
0.19%
$16.0201
KWON YOUNGdirector
241441
0.1021%
$16.0221+57.32%
Tade Brad L.CFO and Treasurer
199433
0.0844%
$16.0201
Guiheen Lawrence P.director
153941
0.0651%
$16.0251<0.0001%
PERCEPTIVE ADVISORS LLC10 percent owner
13262375
5.6104%
$16.0239<0.0001%
Biotest Divestiture Trust10 percent owner
4295580
1.8172%
$16.0202
Aisling Capital II LP10 percent owner
3620143
1.5314%
$16.0210
Burrill Capital Fund IV, L.P.10 percent owner
1433304
0.6063%
$16.0210
LENZ BRIANEVP, CFO
782013
0.3308%
$16.02152+5.59%
Mond JamesEVP, CSO and CMO
73174
0.031%
$16.0280+2.86%
RICHMAN ERIC Idirector
36530
0.0155%
$16.0230+39.74%
DEMSKI MARTHA Jdirector
4200
0.0018%
$16.0220<0.0001%
Fong Bryantdirector
0
0%
$16.0201
Biotest AG10 percent owner
0
0%
$16.0211+103.33%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$120.12M7.8518.2M+1.57%+$1.86M<0.01
The Vanguard Group$83.75M5.4712.69M-1.57%-$1.34M<0.01
State Street$69.65M4.5510.55M+11.28%+$7.06M<0.01
Nuveen$69.06M4.5110.46M-7.87%-$5.9M0.02
Invesco$51.51M3.377.8M+27.69%+$11.17M0.01
American Century Investments$47.05M3.087.13M+4.64%+$2.08M0.03
Perceptive Advisors$42.46M2.786.43M0%+$00.03
Awm Investment Company Inc$37.72M2.475.71M-4.75%-$1.88M5.73
D. E. Shaw & Co.$35.52M2.325.38M-17.38%-$7.47M0.03
Geode Capital Management$31.72M2.074.81M+3.4%+$1.04M<0.01
Magnetar Capital$30.75M2.014.66M-25.84%-$10.71M0.9
Two Sigma$25.38M1.663.85M+23.86%+$4.89M0.04
Morgan Stanley$25.19M1.653.82M+0.86%+$214,770.60<0.01
Dimensional Fund Advisors$23.75M1.553.6M+3.06%+$706,034.980.01
Two Sigma Advisers LP$22.83M1.493.46M+24.55%+$4.5M0.04
Ophir Asset Management$22.63M1.483.43MNew+$22.63M3.97
Stonepine Capital Management Llc$22.62M1.483.43M-62.84%-$38.25M1.36
Assenagon Asset Management S.A.$22.09M1.443.35M-15.18%-$3.95M0.05
Deutsche Bank$20.15M1.323.05M-0.09%-$18,955.200.01
Oberweis Asset Management Inc$18.42M1.22.79M+2.95%+$528,000.001.33
Mesirow Institutional Investment Management Inc$17.22M1.132.61MNew+$17.22M1.54
Driehaus Capital Management LLC$17.03M1.112.58M-21.16%-$4.57M0.17
Northern Trust$13.94M0.912.11M-3.88%-$563,448.61<0.01
Renaissance Technologies$13.25M0.872.01M+89.71%+$6.26M0.02
Charles Schwab$11.72M0.771.78M+8.46%+$913,552.20<0.01
Millennium Management LLC$11.29M0.741.71M-50.46%-$11.5M0.01
Federated Hermes$11.26M0.741.71M+111.41%+$5.93M0.03
Voloridge Investment Management, LLC$11.08M0.721.68MNew+$11.08M0.04
Altium Capital Management Lp$10.16M0.661.54M+40.64%+$2.94M1.19
Velan Capital$10.09M0.661.53M-28.44%-$4.01M5.49
Rice Hall James & Associates, LLC$7.96M0.521.21MNew+$7.96M0.47
Russell Investments Group Ltd$7.72M0.51.17M+90.72%+$3.67M0.01
Cubist Systematic Strategies$6.81M0.451.03M+346.65%+$5.28M0.06
Goldman Sachs$5.97M0.39904,072-47.81%-$5.47M<0.01
CastleArk Management, LLC$5.4M0.35818,110New+$5.4M0.23
AQR Capital$5.39M0.35816,953+38.19%+$1.49M0.01
PEREGRINE CAPITAL MANAGEMENT INC$5.38M0.35815,044-7.69%-$448,397.370.16
Boothbay Fund Management LLC$5.19M0.34786,807-27.8%-$2M0.17
Eam Investors$5.09M0.33771,563New+$5.09M1.18
BNY Mellon$4.73M0.31716,913-8.08%-$415,727.42<0.01
Rafferty Asset Management Llc$4.5M0.29682,265+25.34%+$910,245.600.01
Citigroup$4.18M0.27632,759+139.69%+$2.43M<0.01
Hillsdale Investment Management Inc.$4.16M0.27629,900+41,893.33%+$4.15M0.33
Eam Investors$4.11M0.27622,086New+$4.11M0.25
Wellington Management Company$4.04M0.26612,758+186.36%+$2.63M<0.01
ClariVest Asset Management LLC$3.76M0.25569,225+186.18%+$2.44M0.39
UBS$3.73M0.24565,431+13.47%+$443,071.25<0.01
Calamos Advisors LLC$3.67M0.24556,598+122.47%+$2.02M0.03
Bank of America$3.56M0.23539,421-61.35%-$5.65M<0.0001
State of Wisconsin Investment Board$3.22M0.21487,776+204.74%+$2.16M0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.